Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,661 | 69 | 98.3% |
| Consulting Fee | $46.62 | 1 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $565.20 | 8 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $329.43 | 15 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $278.69 | 9 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $207.08 | 6 | $0 (2024) |
| BioXcel Therapeutics, Inc. | $197.03 | 4 | $0 (2023) |
| Medtronic, Inc. | $174.91 | 1 | $0 (2023) |
| CSL Behring | $170.53 | 3 | $0 (2023) |
| Allergan Inc. | $155.57 | 4 | $0 (2019) |
| PORTOLA PHARMACEUTICALS, INC. | $137.59 | 2 | $0 (2019) |
| Chiesi USA, Inc. | $121.24 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $372.04 | 13 | Gilead Sciences, Inc. ($223.88) |
| 2023 | $847.81 | 21 | Gilead Sciences, Inc. ($242.36) |
| 2022 | $185.60 | 5 | AstraZeneca Pharmaceuticals LP ($140.00) |
| 2021 | $206.60 | 3 | Gilead Sciences, Inc. ($98.96) |
| 2020 | $15.00 | 1 | Janssen Pharmaceuticals, Inc ($15.00) |
| 2019 | $258.99 | 8 | PORTOLA PHARMACEUTICALS, INC. ($137.59) |
| 2018 | $100.86 | 7 | Janssen Pharmaceuticals, Inc ($53.50) |
| 2017 | $720.35 | 12 | E.R. Squibb & Sons, L.L.C. ($214.45) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: DIABETES | ||||||
| 11/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.50 | General |
| 11/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $9.44 | General |
| 09/24/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/11/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: COVID-19 | ||||||
| 06/25/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: VTE | ||||||
| 05/28/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/29/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Rare Disease | ||||||
| 04/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.11 | General |
| 02/28/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/27/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: COVID-19 | ||||||
| 01/23/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $30.39 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/04/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/28/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Rare Disease | ||||||
| 10/24/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Rare Disease | ||||||
| 10/24/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/26/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/20/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: COVID-19 | ||||||
| 09/20/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $54.26 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $90.74 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $33.87 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/30/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/27/2023 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $14.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/12/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 303 | 310 | $370,575 | $37,886 |
| 2022 | 6 | 258 | 259 | $362,224 | $38,282 |
| 2021 | 4 | 290 | 292 | $422,017 | $48,718 |
| 2020 | 4 | 327 | 334 | $475,538 | $51,732 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 112 | 114 | $165,453 | $17,204 | 10.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 49 | 51 | $98,697 | $9,456 | 9.6% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 67 | 68 | $68,489 | $7,038 | 10.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 21 | $28,599 | $3,186 | 11.1% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 12 | 12 | $6,699 | $745.20 | 11.1% |
| 93042 | Electrocardiogram (ecg) 1 to 3 leads with review by physician only | Facility | 2023 | 42 | 44 | $2,638 | $258.28 | 9.8% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 111 | 111 | $170,418 | $18,372 | 10.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 55 | 55 | $107,811 | $11,772 | 10.9% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 39 | 39 | $41,628 | $4,073 | 9.8% |
| 99236 | Hospital observation or inpatient care admitted and discharged on the same day for high severity problem, typically 55 minutes | Facility | 2022 | 13 | 13 | $24,992 | $2,224 | 8.9% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 27 | 28 | $16,569 | $1,763 | 10.6% |
| 93042 | Electrocardiogram (ecg) 1 to 3 leads with review by physician only | Facility | 2022 | 13 | 13 | $806.00 | $77.22 | 9.6% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 154 | 156 | $237,513 | $27,544 | 11.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 59 | 59 | $115,353 | $13,610 | 11.8% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 52 | 52 | $54,679 | $5,835 | 10.7% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 25 | 25 | $14,472 | $1,729 | 11.9% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 159 | 163 | $247,023 | $25,963 | 10.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 85 | 87 | $152,397 | $18,414 | 12.1% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 55 | 56 | $57,458 | $5,831 | 10.1% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 28 | 28 | $18,660 | $1,524 | 8.2% |
About Dr. Eric Handler, DO
Dr. Eric Handler, DO is a Emergency Medicine healthcare provider based in Livingston, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700820446.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Handler, DO has received a total of $2,707 in payments from pharmaceutical and medical device companies, with $372.04 received in 2024. These payments were reported across 70 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,661).
As a Medicare-enrolled provider, Handler has provided services to 1,178 Medicare beneficiaries, totaling 1,195 services with total Medicare billing of $176,617. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Livingston, NJ
- Active Since 06/15/2006
- Last Updated 02/06/2021
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1700820446
Products in Payments
- Veklury (Drug) $513.15
- ANDEXXA (Biological) $344.67
- XARELTO (Drug) $329.43
- ELIQUIS (Drug) $278.69
- DALVANCE (Drug) $263.52
- IGALMI (Drug) $197.03
- ACCURIAN (Device) $174.91
- Kcentra (Biological) $170.53
- CLEVIPREX (Drug) $121.24
- OFIRMEV (Drug) $99.99
- QuikClot (Device) $46.62
- (5044) MCOT (Device) $35.75
- FLOWTRIEVER CATHETER, S (Device) $23.80
- Kimyrsa (Drug) $15.60
- ANAVIP (Biological) $15.00
- JARDIANCE (Drug) $14.42
- Precision Flow (Device) $10.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Livingston
Dr. Leonidas Pritsiolas, M.d, M.D
Emergency Medicine — Payments: $3,832
Neena Gupta, Md, MD
Emergency Medicine — Payments: $2,914
Lejla Mujic, Md, MD
Emergency Medicine — Payments: $2,357
Alexander Fishman, D.o, D.O
Emergency Medicine — Payments: $1,163
Alberto Rivera, Md,Facep, MD,FACEP
Emergency Medicine — Payments: $946.40
Stephanie Huang, Md, MD
Emergency Medicine — Payments: $938.69